Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
During Q3 2025, the Bristol Gate US Equity Strategy lagged the S&P 500 benchmark (-0.6% net return vs 8.1% for S&P 500 TR) due to defensive positioning and a lack of exposure to AI-dominated mega-cap tech stocks and value-based sectors. However, the portfolio...
— Achilleas Taxildaris
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Marsh & McLennan Cos. Inc.
Marsh & McLennan is the preeminent global commercial lines broker, offering a capital-light business structure with resilient recurring revenues. A recent industry...
Marsh & McLennan was a detractor this quarter as the financial sleeve experienced overall relative performance issues. The managers retain...